Acasti Pharma Inc - Class A
Exchange: IEX Type: Common Stock
Price at Close
Change:
Volume:
×
Buy Stock
Remote Buying of Acasti Pharma Inc - Class A through IEX is under development on ETFS.com.
Notify Me when it is ready×
Sell Stock
Remote Selling of Acasti Pharma Inc - Class A through IEX is under development on ETFS.com.
Notify Me when it is ready
Key Statistics
- Open
- Previous Close
- Bid
- Ask
- Day Range -
- 52 Week Range -
- Volume
- Avg. Volume
- Volume to USD
- Market Cap
- Beta
- PE Ratio
- Latest EPS
- EPS TTM
- Dividend
- Dividend Yield
- Ex-Dividend Date
- Revenue TTM
- Revenue per Share
- Revenue per Employee
- Profit Margin
- Gross Profit TTM
- Total Cash TTM
- Total Debt TTM
Share Distribution
- Shares Outstanding
- Float
- Short Interest
- Short Ratio
- Insider Ownership
- Institution Ownership
Latest Headlines
Amryt Pharma plc (NASDAQ:AMYT) Sees Large Increase in Short Interest via ETF Daily News
Swinburne Uni brings Web3 firms to class via Cointelegraph
Retirement Plan Tax Breaks Leave the Middle Class Behind via ETF Trends
Acasti Pharma Inc - Class A Performance
Active Alerts for IEX:ACST
You don't have any alerts set for IEX:ACST.
About Acasti Pharma Inc - Class A
Acasti Pharma, Inc. engages in the development and commercialization of pharmaceutical applications of its licensed rights for cardiovascular diseases. It focuses on the research of prescription drugs using omega-3, fatty acids derived from krill oil. The company was founded by Henri Harland on February 1, 2002 and is headquartered in Laval, Canada.
Real-time ACST to USD Trade Analysis on IEX
Market Status Closed
Analysis is available when the exchange & market are open.